Deferiprone

2 Drugs classified under this active ingredient

Iron Chelating Agent. Deferiprone 500 mg, 1000 mg.
Tabs. 100/50
25 mg/kg BW, orally, X3/d  (total daily dose of 75 mg/kg BW). Dose per kg BW should be calc. to the nearest 1/2 tab.
Tmt of iron overload in pts over 6 years old who suffer from thalassemia major when deferoxamine ther. is contraindic. or inadequate.
C/I:  - Hypersens. – Hist. of recurrent episodes of neutropenia. – Hist. of agranulocytosis. - Pregn- Breast-feeding - Due to the unknown mechan. of deferiprone-induced neutropenia, pts. must not take medic. prod. known to be associated with neutropenia or that can cause agranulocytosis

Chelating Agent. Deferiprone 500 mg, 100 mg/ml.
F.C. TABS: 100. 25 mg/kg bdy wt. 3 x dly
(total dly dose: 75 mg/kg bdy wt.),
calculated to nearest 1/2 tab. Over 100
mg/kg bdy wt not recommend.
Iron overload in pts. over 6 yrs. with
thalassem. major when deferoxamine C/I
or inad. Tmt. by physician experienced in
thalassem.